Literature DB >> 24157855

Non-viable Borrelia burgdorferi induce inflammatory mediators and apoptosis in human oligodendrocytes.

Geetha Parthasarathy1, Helene B Fevrier, Mario T Philipp.   

Abstract

In previous studies, exposure to live Borrelia burgdorferi was shown to induce inflammation and apoptosis of human oligodendrocytes. In this study we assessed the ability of non-viable bacteria (heat killed or sonicated) to induce inflammatory mediators and cell death. Both heat-killed and sonicated bacteria induced release of CCL2, IL-6, and CXCL8 from oligodendrocytes in a dose dependent manner. In addition, non-viable B. burgdorferi also induced cell death as evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and another cell viability assay. These results suggest that spirochetal residues left after bacterial demise, due to treatment or otherwise, may continue to be pathogenic to the central nervous system.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Apoptosis; B. burgdorferi; ELISA; Inflammation; LB; Lyme borreliosis; Lyme neuroborreliosis; MTT; Oligodendrocytes; PMA; PTLDS; TUNEL; enzyme-linked immuno sorbent assay; phorbol myristate acetate; post-treatment Lyme disease syndrome; terminal deoxynucleotidyl transferase dUTP nick end labeling

Mesh:

Substances:

Year:  2013        PMID: 24157855      PMCID: PMC3856578          DOI: 10.1016/j.neulet.2013.10.032

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.

Authors:  Linda K Bockenstedt; David G Gonzalez; Ann M Haberman; Alexia A Belperron
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

2.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

3.  Dual phases of apoptosis in pneumococcal meningitis.

Authors:  Lauren Mitchell; S Hope Smith; Johann S Braun; Karl-Heinz Herzog; Joerg R Weber; Elaine I Tuomanen
Journal:  J Infect Dis       Date:  2004-11-03       Impact factor: 5.226

4.  Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis.

Authors:  Andrea L F Bernardino; Tereance A Myers; Xavier Alvarez; Atsuhiko Hasegawa; Mario T Philipp
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

5.  Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis.

Authors:  Clara García Samartino; M Victoria Delpino; Clara Pott Godoy; María Silvia Di Genaro; Karina A Pasquevich; Astrid Zwerdling; Paula Barrionuevo; Patricia Mathieu; Juliana Cassataro; Fernando Pitossi; Guillermo H Giambartolomei
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

6.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

7.  Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection.

Authors:  John N Aucott; Ari Seifter; Alison W Rebman
Journal:  BMC Infect Dis       Date:  2012-08-01       Impact factor: 3.090

8.  A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi.

Authors:  Geeta Ramesh; Shemi Benge; Bapi Pahar; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2012-04-23       Impact factor: 8.322

9.  Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Authors:  John N Aucott; Alison W Rebman; Lauren A Crowder; Kathleen B Kortte
Journal:  Qual Life Res       Date:  2013-02       Impact factor: 4.147

10.  Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.

Authors:  Monica E Embers; Stephen W Barthold; Juan T Borda; Lisa Bowers; Lara Doyle; Emir Hodzic; Mary B Jacobs; Nicole R Hasenkampf; Dale S Martin; Sukanya Narasimhan; Kathrine M Phillippi-Falkenstein; Jeanette E Purcell; Marion S Ratterree; Mario T Philipp
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

View more
  9 in total

1.  Intracellular TLR7 is activated in human oligodendrocytes in response to Borrelia burgdorferi exposure.

Authors:  Geetha Parthasarathy; Mario T Philipp
Journal:  Neurosci Lett       Date:  2018-02-03       Impact factor: 3.046

2.  Characterization of Brain Dysfunction Induced by Bacterial Lipopeptides That Alter Neuronal Activity and Network in Rodent Brains.

Authors:  Kwang-Min Kim; Alsu I Zamaleeva; Youn Woo Lee; M Rafiuddin Ahmed; Eunkyung Kim; Hye-Ryeon Lee; Venkata Raveendra Pothineni; Juan Tao; Siyeon Rhee; Mithya Jayakumar; Mohammed Inayathullah; Senthilkumar Sivanesan; Kristy Red-Horse; Theo D Palmer; Jon Park; Daniel V Madison; Ho-Young Lee; Jayakumar Rajadas
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

3.  MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi.

Authors:  Timothy Casselli; Humaira Qureshi; Elizabeth Peterson; Danielle Perley; Emily Blake; Bradley Jokinen; Ata Abbas; Sergei Nechaev; John A Watt; Archana Dhasarathy; Catherine A Brissette
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

4.  Primary Human Microglia Are Phagocytically Active and Respond to Borrelia burgdorferi With Upregulation of Chemokines and Cytokines.

Authors:  Jacob R Greenmyer; Robert A Gaultney; Catherine A Brissette; John A Watt
Journal:  Front Microbiol       Date:  2018-04-25       Impact factor: 5.640

5.  Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET.

Authors:  Jennifer M Coughlin; Ting Yang; Alison W Rebman; Kathleen T Bechtold; Yong Du; William B Mathews; Wojciech G Lesniak; Erica A Mihm; Sarah M Frey; Erica S Marshall; Hailey B Rosenthal; Tristan A Reekie; Michael Kassiou; Robert F Dannals; Mark J Soloski; John N Aucott; Martin G Pomper
Journal:  J Neuroinflammation       Date:  2018-12-19       Impact factor: 8.322

6.  Reappraisal of Human HOG and MO3.13 Cell Lines as a Model to Study Oligodendrocyte Functioning.

Authors:  Kim M A De Kleijn; Wieteke A Zuure; Jolien Peijnenborg; Josje M Heuvelmans; Gerard J M Martens
Journal:  Cells       Date:  2019-09-17       Impact factor: 6.600

7.  Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo.

Authors:  Geetha Parthasarathy; Shiva Kumar Goud Gadila
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.996

8.  Borrelia burgdorferi modulates the physical forces and immunity signaling in endothelial cells.

Authors:  Raúl Aparicio Yuste; Marie Muenkel; Konstantinos Axarlis; María J Gómez Benito; Annalena Reuss; Grace Blacker; Michal Caspi Tal; Peter Kraiczy; Effie E Bastounis
Journal:  iScience       Date:  2022-07-20

9.  Supporting patients with long-term problems after Lyme disease.

Authors:  Victoria Cairns
Journal:  BJGP Open       Date:  2020-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.